Advanta bioKEMIX has officially entered India, signalling a bold push to overhaul how global chemical supply chains are built and run. 

Positioned as the India-and-China-facing arm of bioKEMIX Worldwide, the company aims to replace fragmented, multi-layered systems with a tightly integrated ecosystem spanning sourcing, manufacturing, and research. 

Senior leadership marked the launch, including Samith Bajaj, Executive Director, alongside Sameer Bajaj, Managing Director of bioKEMIX Worldwide, Abhishek Sharma, Chief Marketing Officer, and Ravinder Tanwar, Chief Technology Officer—highlighting a unified leadership drive behind the India strategy. 

The timing is critical. The global chemical sector is rapidly shifting away from outdated supply chains riddled with intermediaries toward faster, more direct, and collaborative models. Advanta bioKEMIX is stepping into this transition, positioning itself at the core of a streamlined value chain—from raw material sourcing to finished product optimization—focused on speed, reliability, and consistency. 

Backing this ambition, bioKEMIX Worldwide has committed an investment of approximately Rs. 220 crore (around EUR 20 million) in India over the next five years. The funds will expand manufacturing capabilities and deepen the company’s operational footprint, reinforcing India’s emergence as a key global hub for chemical production and innovation. 

“Advanta bioKEMIX represents a fundamental shift in how chemical supply chains are designed and delivered. Our vision is to move beyond fragmented systems and build an integrated, transparent, and globally connected ecosystem that aligns sourcing, manufacturing, and research into a single, seamless network,” said Samith Bajaj, Executive Director, Advanta bioKEMIX.  

“India is central to this vision—not just as a manufacturing base, but as a strategic hub for innovation and value creation. Through our investment and partnerships here, we are committed to enabling faster, more reliable, and more scalable solutions for global markets, while contributing to the evolution of a more resilient and future-ready chemical industry.” 

At the heart of Advanta bioKEMIX’s model are three tightly linked verticals: sourcing, production, and research. The sourcing arm aims to consolidate fragmented supplier networks, the production arm leverages a flexible partner-driven manufacturing system, and the research arm focuses on innovation, efficiency, and precision-driven outcomes tailored to market needs. 

By integrating these functions, the company is targeting faster development cycles, reduced supply chain friction, and scalable, high-quality solutions for global brands within the bioKEMIX network. Its broader strategy connects eastern manufacturing strengths with western demand, creating a more agile and resilient global chemical ecosystem.